The guideline defines acceptable data requirements for the demonstration of quality of veterinary medicinal products other than biologicals classified as limited markets in line with Article 4(29) of Regulation (EU) 2019/6.

Keywords: availability, limited market, classification, Article 4, Article 8, Article 23, Annex II, Regulation (EU) 2019/6, non-biological veterinary medicinal products, quality, data requirements

Current version

Document history

Share this page